76 related articles for article (PubMed ID: 1295127)
1. The characteristics of interval breast cancer in mass screening.
Morimoto T; Komaki K; Oshimo K; Miki H; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Monden Y
Tokushima J Exp Med; 1992 Dec; 39(3-4):109-16. PubMed ID: 1295127
[TBL] [Abstract][Full Text] [Related]
2. [A comparative analysis of interval breast cancer with breast cancer detected by mass screening or in outpatient clinics].
Komaki K; Morimoto T; Oshimo K; Mori T; Sasa M; Konishi Y; Monden Y
Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):413-8. PubMed ID: 1603047
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer detected by mass screening using physical examination alone].
Morimoto T; Komaki K; Monden Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):944-51. PubMed ID: 3389838
[TBL] [Abstract][Full Text] [Related]
5. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
6. Management of bilateral breast carcinoma: long-term results.
Goksel HA; Yagmurdur MC; Karakayali H; Moray G; Demirhan B; Isiklar I; Bilgin N; Haberal M
Int Surg; 2004; 89(3):166-71. PubMed ID: 15521255
[TBL] [Abstract][Full Text] [Related]
7. [Mass screening for breast cancer in Japan].
Ota J
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2210-6. PubMed ID: 1929440
[TBL] [Abstract][Full Text] [Related]
8. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
9. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
10. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
11. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme.
Ascunce EN; Moreno-Iribas C; Barcos Urtiaga A; Ardanaz E; Ederra Sanz M; Castilla J; Egüés N
J Med Screen; 2007; 14(1):14-20. PubMed ID: 17362566
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mass screening for thyroid cancer.
Ishida T; Izuo M; Ogawa T; Kurebayashi J; Satoh K
Jpn J Clin Oncol; 1988 Dec; 18(4):289-95. PubMed ID: 3204679
[TBL] [Abstract][Full Text] [Related]
13. The natural history of breast carcinoma: what have we learned from screening?
Tabár L; Duffy SW; Vitak B; Chen HH; Prevost TC
Cancer; 1999 Aug; 86(3):449-62. PubMed ID: 10430253
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
16. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.
Arnesson LG; Smeds S; Fagerberg G
Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195
[TBL] [Abstract][Full Text] [Related]
17. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program.
Hofvind S; Sørum R; Thoresen S
Acta Oncol; 2008; 47(2):225-31. PubMed ID: 17851868
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of screen-detected breast cancers: results of a population based study.
Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
[TBL] [Abstract][Full Text] [Related]
19. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
20. Prognostic assessment of histologic parameters in breast carcinomas: a prospective study.
Niezabitowski A; Skołyszewski J; Ryś J; Gruchała A; Sokołowski A; Stelmach A; Lackowska B; Sklarski W; Wasilewska A; Kruczak A; Swiatkiewicz I
Gen Diagn Pathol; 1998 Apr; 143(5-6):279-85. PubMed ID: 9653908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
